Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126034 · ClinicalTrials.gov registry record · NA
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT01126034: Completed NA study, sponsored by University of Pennsylvania.
NCT01126034 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126034, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The investigators hypothesized that: 1\) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.
Interventions
- OTHER intervention letter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01126034
The ClinicalTrials.gov registry entry for NCT01126034 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intervention letter is the first listed.
NCT01126034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01126034 about?
NCT01126034 is a clinical study titled "Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention". The investigators hypothesized that: 1\) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.
What is the current status of trial NCT01126034?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2007-03. Estimated completion is 2008-04.
What interventions are being tested in trial NCT01126034?
The interventions under investigation include: intervention letter (OTHER).
Who is sponsoring clinical trial NCT01126034?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.